Tamtam Try Tamtam free
Kry logo

Kry account plan

Digital Healthcare Provider

At a glance

Kry (Livi in the UK and France) is a Stockholm-based provider of digital and physical healthcare with revenue of SEK 2.5 billion in 2025.

Kry International AB is a private, investor-backed healthcare provider that combines digital consultations with a network of physical clinics in Sweden, Norway, France and the UK. Livi, the name used in the UK and France, is being rebranded to Kry; the release of 8 September 2026 says the Livi brand will be gradually phased out and the wider business remains unchanged. FY2024 net sales were 2,489,581 kSEK with a loss after financial items of -525,153 kSEK, and the company states 2025 revenue of SEK 2.5 billion and EBITDA of SEK 17 million. The group had an average of 1,591 employees in 2024 and approximately 4,000 healthcare professionals.

Business units

Strategic priorities

Reach profitability
The annual report states Kry's main goal is to become profitable. The EBITDA margin improved from -19.5% to -4.4% in 2024, and the company states 2025 EBITDA of SEK 17 million.
Scale the digiphysical model
Kry plans to expand its digital offloading model across its four markets, increasing the share of digital-first consultations and integrating digital and physical healthcare.
One European brand
Livi in the UK and France becomes Kry, so that the shared technology platform and ways of working carry the same name everywhere.
Grow in France
The 2025 strategy was to expand on a large scale by launching specialist areas and new disciplines such as paediatrics, obesity and gynaecology, and a first medical centre opens in Paris in September 2026.
Consolidate Sweden through acquisition
Kry announced on 12 November 2026 the acquisition of Min Doktor, which had approximately SEK 400 million revenue in 2025; it is subject to regulatory approval.

Latest results

Kry states that in 2025 revenue amounted to SEK 2.5 billion and EBITDA to SEK 17 million, against an EBITDA of SEK -505 million in 2024 and a margin of -4.4%. The FY2024 results release of 24 June 2025 said all markets returned a profit at the end of 2024 and that the trend continued in the first quarter of 2025. No quarterly report for 2026 is in the documents read.

Investments and deals

Min Doktor acquisition
Announced 12 November 2026; Apotek Hjartat and EQT Ventures become shareholders in Kry. Min Doktor had nearly 100 sites, revenue of approximately SEK 400 million and EBITDA of approximately SEK 27 million in 2025.
Bolt-on clinic acquisitions
Since 2020 Kry has acquired Helsa, PBM, Citylakarna, Trygga Kliniken, Adavia Group, Hudlakartjanst and Hermelinen; Medinord was acquired in 2026.
Financing and ownership restructuring
EUR 20 million convertible loan in March 2024 and a conversion in October 2024 that raised equity by SEK 1,468 million to SEK 448 million.
New physical sites
Kry took over operation of Kungsbacka Lattakut in Region Halland on 1 January 2025 and plans a Paris medical centre in September 2026.

Challenges and risks

Regional repayment claims
Region Stockholm demands SEK 48 million and Region Skane SEK 18.8 million back; Kry considers both unfounded and has disputed them.
Regulatory dependence
Policy decisions in the publicly funded systems of Sweden, France and the UK can significantly affect Kry, and the Norwegian public primary care market is largely closed to private providers.
Loss-making history
The FY2024 loss after financial items was -525,153 kSEK and cash flow from operating activities was -509,302 kSEK.
UK scale
UK revenue fell from 294,443 kSEK to 247,756 kSEK in 2024, and the annual report says challenges surrounding scalability remain in the UK.

What leadership says

“We have grown from being a Swedish digital challenger into a large and established healthcare provider across several European markets.”

Kalle Conneryd Lundgren, CEO · Kry press release on the Livi rebrand, 8 September 2026

“Our ambition has always been the same: to build Europe's leading healthcare provider and help move healthcare into the future.”

Johannes Schildt, Founder and Chair · Kry press release on the Livi rebrand, 8 September 2026

“We are using AI in production”

Kalle Conneryd Lundgren, COO of Livi (now CEO) · HTN interview, 6 March 2024

Where a supplier can help

Clinic operations and productivity tooling
Kry adds clinics through acquisitions such as Min Doktor and Hermelinen and cites record measured productivity, so scheduling, patient-flow and admin-reduction suppliers can help integrate sites.
Integration of acquired businesses
With the Min Doktor deal and a list of bolt-on acquisitions, integration, IT consolidation and finance-systems support are relevant to its consolidation priority.
Cost and billing compliance
The SEK 48 million and SEK 18.8 million repayment claims point to a need for billing audit, appointment registration and compliance tooling.
Rebrand and partnership marketing
The shift from Livi to Kry in the UK and France, and partnerships such as Klarna, create work for brand, patient-acquisition and partner-channel suppliers.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Kry?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Kry

What does Kry do?

Kry is a European healthcare provider that combines digital care with a network of physical clinics, covering primary care, specialist care and occupational health in Sweden, Norway, France, the UK and, per the November 2026 release, Ireland.

Is Livi still operating in France and the UK?

Livi is being rebranded to Kry in the UK and France; the release of 8 September 2026 says the Livi brand will be gradually phased out and the business otherwise remains unchanged. No sale or closure is stated.

What is Kry's revenue?

Kry's FY2024 net sales were 2,489,581 kSEK, and the company states that 2025 revenue was SEK 2.5 billion with EBITDA of SEK 17 million.

Who runs Kry?

Kalle Conneryd Lundgren has been CEO since December 2024; founder Johannes Schildt is Chairman.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-19)